RECENT FUNDING ROUNDS
| Company | Country | Profile | Funding round | Value | Date | |
|---|---|---|---|---|---|---|
| |
Vivodyne Inc | Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. | Seed | USD 38,000,000 | ||
| |
47 Labs | Healthcare through neuro-simulation. | Pre Seed | |||
| |
ValenzaBio Inc | antibody for inflammatory eye disease | Series A | USD 70,000,000 | ||
| |
Blossomhill Therapeutics Inc | Biotechnology company focused on oncology and autoimmune disorders. | Series A | USD 71,000,000 | ||
| |
Maridose LLC | Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. | Pre Seed | USD 150,000 | ||
| |
Perfect Day Inc | Series C | USD 140,000,000 | |||
| |
Quell Therapeutics Ltd | Developer of engineered T regulatory cell therapies. | Series A | GBP 35,000,000 | ||
| |
Aquaro Histology Inc | Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. | Series A | USD 9,810,879 | ||
| |
20n | Using AI to predict biochemistry for manufacturing and therapeutics. | Seed | |||
| |
3SBio Inc | IPO | HKD 5,510,000,000 |
MOST ACTIVE INVESTORS
| Braemar Energy Ventures LLC | US | 2 |
| Y Combinator | US | 2 |
| Bunge Ltd | US | 1 |
| Chevron Technology Ventures LLC | US | 1 |
| CTTV Investments LLC | US | 1 |
| Harris & Harris Group Inc | US | 1 |
| Lightspeed Management Co LLC | US | 1 |
| Morgan Stanley & Co Inc | US | 1 |
| The Roda Group | US | 1 |
| San-Ei Gen FFI Inc | GB | 1 |
MOST ACTIVE ACQUIRERS
| Pfizer Inc | US | 1 |
| Nestlé SA | CH | 1 |
BEST FUNDED
Biotechnology company focused on oncology and autoimmune disorders.
Philadelphia-based biotech that tests its drug candidates on lab-grown human organs.
Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.
Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.
Biotechnology company focused on developing new products to eliminate bacterial infections.
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.
A cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called “pRNA”
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Renewable oil and bioproducts company and the leader in algal biotechnology